Cargando…

TNF-α Inhibitors Decrease Classical CD14(hi)CD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis

Monocytes are pivotal cells in inflammatory joint diseases. We aimed to determine the effect of TNF-α inhibitors (TNFi) on peripheral blood monocyte subpopulations and their activation in ankylosing spondylitis (AS) and rheumatoid arthritis (RA) patients with high disease activity. To address this,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batko, Bogdan, Schramm-Luc, Agata, Skiba, Dominik S., Mikolajczyk, Tomasz P., Siedlinski, Mateusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358965/ https://www.ncbi.nlm.nih.gov/pubmed/30642076 http://dx.doi.org/10.3390/ijms20020291

Ejemplares similares

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells
por: Schramm-Luc, Agata, et al.
Publicado: (2018)

Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
por: Batko, Bogdan, et al.
Publicado: (2018)

Increased frequency of circulating CD19+CD24(hi)CD38(hi) B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents
por: Bautista-Caro, María-Belén, et al.
Publicado: (2017)

Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis
por: Aeberli, Daniel, et al.
Publicado: (2016)

Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients
por: Moskal, Mateusz, et al.
Publicado: (2022)

Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis
por: Schirmer, Michael, et al.
Publicado: (2002)

Gender difference in ASAS HI among patients with ankylosing spondylitis
por: Chen, Hsin-Hua, et al.
Publicado: (2020)

Anti-TNF-α Therapy for Ankylosing Spondylitis
por: Son, Jung-Hwan, et al.
Publicado: (2010)

T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis
por: WANG, CHENGGONG, et al.
Publicado: (2015)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis
por: Yang, Mingcan, et al.
Publicado: (2020)

Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis
por: Schirmer, M, et al.
Publicado: (2001)

CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis
por: Wu, Fengqing, et al.
Publicado: (2022)

Aging of classical monocyte subsets
por: Goodridge, Helen S.
Publicado: (2023)

CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so
por: Zhou, Jingling, et al.
Publicado: (2015)

GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis
por: Shi, Hui, et al.
Publicado: (2020)

Erratum to: CD14 hi CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so
por: Zhou, Jingling, et al.
Publicado: (2015)

Prevalence, clinical relevance and characterization of circulating cytotoxic CD4(+)CD28(- )T cells in ankylosing spondylitis
por: Duftner, Christina, et al.
Publicado: (2003)

CD1d(hi)PD-L1(hi)CD27(+) Regulatory Natural Killer Subset Suppresses Atopic Dermatitis
por: Min, Keun Young, et al.
Publicado: (2022)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

Functional defects in CD4(+) CD25(high) FoxP3(+) regulatory cells in ankylosing spondylitis
por: Guo, Huifang, et al.
Publicado: (2016)

Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis
por: Liu, Dong, et al.
Publicado: (2021)

CD14CD16 Monocyte Subset Levels in Heart Failure Patients
por: Barisione, Chiara, et al.
Publicado: (2010)

The CD14(+/low)CD16(+) monocyte subset is more susceptible to spontaneous and oxidant-induced apoptosis than the CD14(+)CD16(−) subset
por: Zhao, C, et al.
Publicado: (2010)

In-Depth Proteomic Characterization of Classical and Non-Classical Monocyte Subsets
por: Segura, Víctor, et al.
Publicado: (2018)

Lineage Commitment in the Thymus: Only the Most Differentiated (TCR(hi)bcl-2(hi)) Subset of CD4(+)CD8(+)Thymocytes Has Selectively Terminated CD4 or CD8 Synthesis
por: Punt, Jennifer A., et al.
Publicado: (1996)

Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis
por: Maatallah, Kaouther, et al.
Publicado: (2018)

Machine learning to predict early TNF inhibitor users in patients with ankylosing spondylitis
por: Lee, Seulkee, et al.
Publicado: (2020)

Association of anti-TNF-α treatment with gut microbiota of patients with ankylosing spondylitis
por: Dai, Qinghong, et al.
Publicado: (2022)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
por: Coşkun, Belkıs Nihan, et al.
Publicado: (2022)

Clinical significance of the monocyte:lymphocyte ratio for ankylosing spondylitis patients with thoracolumbar kyphotic deformities
por: Zhuang, Jianxiong, et al.
Publicado: (2020)

Changes in the Monocytic Subsets CD14(dim)CD16(+) and CD14(++)CD16(−) in Chronic Systolic Heart Failure Patients
por: Amir, Offer, et al.
Publicado: (2012)

CD19(+)CD24(hi)CD38(hi) B Cell Dysfunction in Primary Biliary Cholangitis
por: Chen, Qubo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ole5l0e6pvg5u5hneni529a6f7